Evidence map›Paper›PMID 23860694›Full record

ArticleWiener klinische Wochenschrift2013

A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis B infection.

Bahadir Ceylan, Bilgül Mete, Muzaffer Fincanci, Turan Aslan, Yasemin Akkoyunlu, Nail Ozguneş, Onur Colak, Alper Gunduz, Ebubekir Senates, Resat Ozaras and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Wiener klinische Wochenschrift, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Mean platelet volume may be confused in many conditions.Wiener klinische Wochenschrift · 2014
    Article
  13. Evaluation of mean platelet volume in patients with hepatitis B virus infection.International journal of clinical and experimental medicine · 2014
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Bahadir CeylanDepartment of Infectious Diseases and Clinical Microbiology, Bezmialem Vakif University, Vatan Caddesi, Fatih İlçesi, Istanbul, Turkey. bceylan2004@yahoo.com
Bilgül Mete
Muzaffer Fincanci
Turan Aslan
Yasemin Akkoyunlu
Nail Ozguneş
Onur Colak
Alper Gunduz
Ebubekir Senates
Resat Ozaras
Ayşe Inci
Fehmi Tabak

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe aimed to investigate whether mean platelet volume (MPV) and platelet distribution width (PDW) are variables determining the severity of liver fibrosis in patients with chronic HBV infection.

methodsPatients were divided into two groups with fibrosis scores of 0-2 and 3-6 (according to Ishac scoring system). Whether MPV and PDW were independent variables determining the severity of liver fibrosis score or not was investigated by comparing these groups.

resultsOf the 111 cases, 74 (66.7 %) were male (mean age 37.7 ± 11.6 years). Twenty-two of the cases (19.8 %) were HBeAg-positive. Fibrosis scores of 42 cases (37.8 %) were ≥ 3 and the remaining 69 cases had fibrosis scores < 3 (62.2 %). Independent variables determining the severity of fibrosis score were low levels of albumin and mean platelet volume, and high levels of prothrombin time and PDW (Odds ratio (95 % confidence interval) and p values were 0.105 (0.018-0.605) and 0.012 for albumin, 0.402 (0.234-0.692) and 0.001 for mean platelet volume, 1.529 (1.183-1.975) and 0.001 for PDW, and 0.924 (0.875-0.976) and 0.005 for prothrombin time, respectively). The sensitivity, specificity, positive predictive value and negative predictive value of regression model that is established using above mentioned parameters were 88.1, 75.3, 68.5, and 91.7 %, respectively (AUC = 0.886, p = 0.0001).

conclusionsMPV and PDW are independent variables determining the severity of liver fibrosis, and the regression model that is established using these parameters along with other markers, may give more information about the severity of liver fibrosis.

Indexed as

AdultCausalityComorbidityFemaleHepatitis B, ChronicHumansLiver CirrhosisMaleMean Platelet VolumePlatelet CountPrevalencePrognosisReproducibility of ResultsRisk FactorsSensitivity and SpecificitySeverity of Illness Index

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.